CATALOGO DEI PRODOTTI DELLA RICERCA

Merz, Valeria
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
EU - Europa 1.632
NA - Nord America 1.346
AS - Asia 1.002
SA - Sud America 133
AF - Africa 27
OC - Oceania 4
Continente sconosciuto - Info sul continente non disponibili 1
Totale 4.145
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 1.316
RU - Federazione Russa 773
SG - Singapore 389
CN - Cina 333
IT - Italia 195
DE - Germania 165
GB - Regno Unito 132
BR - Brasile 109
HK - Hong Kong 96
IE - Irlanda 84
SE - Svezia 79
FR - Francia 72
VN - Vietnam 63
FI - Finlandia 57
KR - Corea 32
CA - Canada 24
IN - India 19
NL - Olanda 15
JP - Giappone 13
UA - Ucraina 13
AR - Argentina 12
AT - Austria 11
ID - Indonesia 9
BJ - Benin 8
TG - Togo 8
TR - Turchia 8
PL - Polonia 7
BD - Bangladesh 6
ZA - Sudafrica 6
CZ - Repubblica Ceca 5
ES - Italia 5
IQ - Iraq 5
AU - Australia 4
SA - Arabia Saudita 4
BE - Belgio 3
CH - Svizzera 3
JO - Giordania 3
MX - Messico 3
VE - Venezuela 3
AM - Armenia 2
AZ - Azerbaigian 2
DZ - Algeria 2
EC - Ecuador 2
IR - Iran 2
KZ - Kazakistan 2
LB - Libano 2
LT - Lituania 2
PE - Perù 2
PK - Pakistan 2
PT - Portogallo 2
PY - Paraguay 2
UZ - Uzbekistan 2
AL - Albania 1
BG - Bulgaria 1
BS - Bahamas 1
BY - Bielorussia 1
CL - Cile 1
CO - Colombia 1
CR - Costa Rica 1
DK - Danimarca 1
EU - Europa 1
GI - Gibilterra 1
HN - Honduras 1
KE - Kenya 1
KH - Cambogia 1
LA - Repubblica Popolare Democratica del Laos 1
LU - Lussemburgo 1
LV - Lettonia 1
MA - Marocco 1
MY - Malesia 1
NO - Norvegia 1
NP - Nepal 1
OM - Oman 1
PS - Palestinian Territory 1
QA - Qatar 1
SK - Slovacchia (Repubblica Slovacca) 1
TH - Thailandia 1
TN - Tunisia 1
UY - Uruguay 1
Totale 4.145
Salva come PNG Salva come JPEG
Città #
Moscow 312
Dallas 256
Singapore 209
Ashburn 199
Chandler 181
Hong Kong 96
Southend 91
Dublin 85
Munich 62
Beijing 59
Verona 38
Los Angeles 34
Woodbridge 33
Jacksonville 31
The Dalles 29
Helsinki 27
Ho Chi Minh City 27
New York 26
Turku 25
Jinan 23
Lawrence 20
Princeton 20
Tianjin 20
Wilmington 19
London 16
Rome 16
Buffalo 14
Milan 14
São Paulo 14
Taiyuan 14
Frankfurt am Main 13
Columbus 12
Santa Clara 12
Sindelfingen 12
Changsha 11
Toronto 11
Denver 10
Kent 10
Seattle 10
Shenyang 10
Atlanta 9
Haikou 9
Hanoi 9
Montreal 9
Nuremberg 9
Redondo Beach 9
Tokyo 9
Washington 9
Cotonou 8
Hebei 8
Lomé 8
Redwood City 8
Taizhou 8
Amsterdam 7
Hangzhou 7
Houston 7
Jakarta 7
Monza 7
Warsaw 7
Nanchang 6
Nanjing 6
Ningbo 6
Stockholm 6
Ann Arbor 5
Boston 5
Chennai 5
Chicago 5
Fairfield 5
Fuzhou 5
Guangzhou 5
Jiaxing 5
Johannesburg 5
Nürnberg 5
Phoenix 5
Rio de Janeiro 5
San Francisco 5
Seoul 5
Treviso 5
Bologna 4
Marseille 4
Redmond 4
Vienna 4
Zhengzhou 4
Amman 3
Baghdad 3
Boardman 3
Brasília 3
Brescia 3
Brno 3
Brooklyn 3
Brussels 3
Council Bluffs 3
Da Nang 3
Dhaka 3
Frignano 3
Jining 3
Kolkata 3
Marsala 3
Meda 3
Mumbai 3
Totale 2.445
Salva come PNG Salva come JPEG
Nome #
An FGFR3 autocrine loop sustains acquired resistance to trastuzumab in gastric cancer patients 288
A circulating TH2 cytokines profile predicts survival in patients with resectable pancreatic adenocarcinoma 260
A phase II study of liposomal irinotecan with 5-fluorouracil, leucovorin and oxaliplatin in patients with resectable pancreatic cancer: the nITRO trial 217
Adipocytes sustain pancreatic cancer progression through a non-canonical WNT paracrine network inducing ROR2 nuclear shuttling 204
Outcomes of Primary Chemotherapy for Borderline Resectable and Locally Advanced Pancreatic Ductal Adenocarcinoma 202
Angiopoietin-Like Proteins in Angiogenesis, Inflammation and Cancer 177
A phase II trial of the FGFR inhibitor pemigatinib in patients with metastatic esophageal-gastric junction/gastric cancer trastuzumab resistant: the FiGhTeR trial 170
Homeobox B9 Mediates Resistance to Anti-VEGF Therapy in Colorectal Cancer Patients 166
Plasma Interleukin-8 is a biomarker for TAK1 activation and predicts resistance to nanoliposomal irinotecan in patients with gemcitabine-refractory pancreatic cancer 156
Role of next-generation genomic sequencing in targeted agents repositioning for pancreaticoduodenal cancer patients 148
Modulating TAK1 expression inhibits YAP and TAZ oncogenic functions in pancreatic cancer 147
Novel Biomarkers for Prediction of Response to Preoperative Systemic Therapies in Gastric Cancer 144
Multicenter Retrospective Analysis of Second-Line Therapy after Gemcitabine Plus Nab-Paclitaxel in Advanced Pancreatic Cancer Patients 133
Exceptional Clinical Response to Alectinib in Pancreatic Acinar Cell Carcinoma With a Novel ALK-KANK4 Gene Fusion 130
Targeting KRAS: The Elephant in the Room of Epithelial Cancers 127
Autotaxin Secretion Is a Stromal Mechanism of Adaptive Resistance to TGFβ Inhibition in Pancreatic Ductal Adenocarcinoma 124
Pemigatinib, a potent inhibitor of FGFRs for the treatment of cholangiocarcinoma 119
Clinical Response to Futibatinib in Patients with High-Level FGFR2-Amplified Advanced Gastric Cancer: Two Case Reports 114
Predictive Biomarkers for a Personalized Approach in Resectable Pancreatic Cancer 114
Clinical nutrition in surgical oncology: Young AIOM-AIRO-SICO multidisciplinary national survey on behalf of NutriOnc research group 111
Electronic Medical Record-Assisted Telephone Follow-Up of Breast Cancer Survivors During the COVID-19 Pandemic: A Single Institution Experience 110
Perioperative NALIRIFOX in patients with resectable pancreatic ductal adenocarcinoma: The open-label, multicenter, phase II nITRO trial 102
Safety and activity of the TGF beta receptor I kinase inhibitor galunisertib plus the anti-PD-L1 antibody durvalumab in metastatic pancreatic cancer 89
Integration of liposomal irinotecan in the first-line treatment of metastatic pancreatic cancer: try to do not think about the white bear 86
YAP Activation Is Associated with a Worse Prognosis of Poorly Cohesive Gastric Cancer 85
Population pharmacokinetics and exposure-overall survival analysis of the transforming growth factor-β inhibitor galunisertib in patients with pancreatic cancer 83
Multicentre match-paired analysis of advanced biliary cancer long-term survivors: The BILONG study 78
Is There Room for Liposomal Irinotecan in Biliary Tract Cancer? A Meta-analysis of Randomised Trials 73
Third-line chemotherapy in advanced biliary cancers (ABC): pattern of care, treatment outcome and prognostic factors from a multicenter study 73
The role of nanoliposomal irinotecan plus fluorouracil/leucovorin in the continuum of care of patients with metastatic pancreatic ductal adenocarcinoma 64
Second-Line Chemotherapy in Elderly Patients with Advanced Biliary Tract Cancer: A Multicenter Real-World Study 64
Perioperative NALIRIFOX in Patients with Resectable Pancreatic Ductal Adenocarcinoma: An Updated Analysis of Survival and Response Biomarkers from the Phase II nITRO Trial. 39
Totale 4.197
Salva come PNG Salva come JPEG
Categoria #
all - tutte 15.019
article - articoli 14.955
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 64
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 30.038
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021113 0 0 0 0 0 26 1 3 19 43 11 10
2021/2022222 16 87 8 17 1 5 1 13 6 3 11 54
2022/2023492 25 67 34 79 38 130 3 26 64 8 12 6
2023/2024423 7 25 28 34 33 66 69 37 9 23 76 16
2024/2025816 40 37 38 127 30 34 62 40 86 42 112 168
2025/20261.773 144 114 256 413 670 176 0 0 0 0 0 0
Totale 4.197